Log in
NASDAQ:BIS

ProShares UltraShort Nasdaq Biotechnology Stock Forecast, Price & News

$30.29
-0.80 (-2.57 %)
(As of 10/22/2020 12:00 AM ET)
Add
Today's Range
$30.12
Now: $30.29
$30.95
50-Day Range
$27.09
MA: $31.36
$36.03
52-Week Range
$26.93
Now: $30.29
$79.40
Volume23,952 shs
Average Volume59,370 shs
Market Capitalization$13.51 million
P/E RatioN/A
Dividend Yield0.22%
BetaN/A
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.
Read More

Geographic Exposure of BIS

Currency Exposure of BIS

Basic Details

Issuer ProShares
Fund NameProShares UltraShort Nasdaq Biotechnology
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:BIS
Inception Date4/6/2010
Fund ManagerMichael Neches, Tarak Dave
Phone+1-240-4976400

Fund Focus

Asset ClassEquity
BenchmarkNasdaq Biotech Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$19.04 million
Average Daily Volume$100,288.40
Discount/Premium0.02%

ETF Expenses

Management Fee0.75%
Other Expenses0.36%
Total Expenses1.11%
Fee Waiver-0.16%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerVirtu Financial
$30.29
-0.80 (-2.57 %)
(As of 10/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BIS News and Ratings via Email

Sign-up to receive the latest news and ratings for BIS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Frequently Asked Questions

How has ProShares UltraShort Nasdaq Biotechnology's stock been impacted by Coronavirus?

ProShares UltraShort Nasdaq Biotechnology's stock was trading at $64.52 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BIS stock has decreased by 53.1% and is now trading at $30.29.
View which stocks have been most impacted by COVID-19
.

How often does ProShares UltraShort Nasdaq Biotechnology pay dividends? What is the dividend yield for ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology declared a quarterly dividend on Wednesday, March 25th. Shareholders of record on Thursday, March 26th will be paid a dividend of $0.1057 per share on Wednesday, April 1st. This represents a $0.42 annualized dividend and a dividend yield of 1.40%. The ex-dividend date of this dividend is Wednesday, March 25th. This is an increase from ProShares UltraShort Nasdaq Biotechnology's previous quarterly dividend of $0.04.
View ProShares UltraShort Nasdaq Biotechnology's dividend history
.

When did ProShares UltraShort Nasdaq Biotechnology's stock split? How did ProShares UltraShort Nasdaq Biotechnology's stock split work?

ProShares UltraShort Nasdaq Biotechnology shares reverse split on the morning of Tuesday, August 18th 2020. The 1-4 reverse split was announced on Tuesday, August 4th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 17th 2020. An investor that had 100 shares of ProShares UltraShort Nasdaq Biotechnology stock prior to the reverse split would have 25 shares after the split.

Are investors shorting ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology saw a increase in short interest in September. As of September 30th, there was short interest totaling 18,800 shares, an increase of 15.3% from the September 15th total of 16,300 shares. Based on an average daily volume of 92,400 shares, the short-interest ratio is currently 0.2 days.
View ProShares UltraShort Nasdaq Biotechnology's Short Interest
.

What other stocks do shareholders of ProShares UltraShort Nasdaq Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ProShares UltraShort Nasdaq Biotechnology investors own include Sanofi (SNY), Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Quest Diagnostics (DGX), Micron Technology (MU), Pfizer (PFE), (MRNA), Cidara Therapeutics (CDTX) and Vertex Pharmaceuticals (VRTX).

What is ProShares UltraShort Nasdaq Biotechnology's stock symbol?

ProShares UltraShort Nasdaq Biotechnology trades on the NASDAQ under the ticker symbol "BIS."

How do I buy shares of ProShares UltraShort Nasdaq Biotechnology?

Shares of BIS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ProShares UltraShort Nasdaq Biotechnology's stock price today?

One share of BIS stock can currently be purchased for approximately $30.29.

How big of a company is ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology has a market capitalization of $13.51 million.

What is ProShares UltraShort Nasdaq Biotechnology's official website?

The official website for ProShares UltraShort Nasdaq Biotechnology is www.proshares.com.

How can I contact ProShares UltraShort Nasdaq Biotechnology?

ProShares UltraShort Nasdaq Biotechnology's mailing address is SUITE 1000, 7501 WISCONSIN AVENUE, Bethesda, MD 20814, United States. The company can be reached via phone at +1-240-4976400.

This page was last updated on 10/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.